Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Today Bhutan.
Press releases published on July 9, 2025
BioVie Announces Data Highlighting Bezisterim’s Potential to Slow or Reverse Biological Aging and Neurodegeneration Featured as a Keynote Talk at the 7th World Aging and Rejuvenation Conference
GlobeNewswire
·
July 9, 2025
CARSON CITY, Nev., July 09, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver …
Werewolf Therapeutics to Participate in the KidneyCAN 7th Annual Kidney Cancer Research Summit
GlobeNewswire
·
July 9, 2025
WATERTOWN, Mass., July 09, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate …
FluidForm Bio™ Presents Six-Month Efficacy Data of FRESH 3D Bioprinted Human Islet Subcutaneous Scaffolds at the American Diabetes Association (ADA) 85th Scientific Sessions
GlobeNewswire
·
July 9, 2025
WALTHAM, Mass., July 09, 2025 (GLOBE NEWSWIRE) -- FluidForm Bio™, a leader in cell therapies for chronic diseases such as type 1 diabetes, today announced two presentations at recent medical meetings: the 20th World Congress of the International Pancreas …
zSpace Imagine Wins Future’s Best of Show Award at ISTELive25, Presented by Tech & Learning
GlobeNewswire
·
July 9, 2025
SAN JOSE, Calif., July 09, 2025 (GLOBE NEWSWIRE) -- zSpace (NASDAQ: ZSPC) (“zSpace” or the “Company”), a leader in immersive learning, announced today that the Company is a recipient of Future’s Best of Show Award, presented at ISTE 2025 by Tech …
‘Lavender & The Butterfly Nation’ Pushes Boundaries with World’s First GenAI-Hybrid Animated Feature
GlobeNewswire
·
July 9, 2025
LONDON, July 09, 2025 (GLOBE NEWSWIRE) -- IMAGENai Inc., a boundary-pushing GenAI creative studio, unveils its pioneering animated feature, Lavender …
Amneal to Report Second Quarter 2025 Results on August 5, 2025
GlobeNewswire
·
July 9, 2025
BRIDGEWATER, N.J., July 09, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal” or the “Company”), a global biopharmaceutical company, today announced that the Company will release its second quarter 2025 financial results on …
Introducing Aptean Fresh Produce ERP: The Next-Generation of Produce Pro Software
GlobeNewswire
·
July 9, 2025
Unifying Decades of Fresh Produce Expertise with Cutting-Edge Technology in a Powerful, Cloud-Based ERP Solution ALPHARETTA, Ga., July 09, 2025 (GLOBE NEWSWIRE) -- Aptean, a global leader in mission-critical enterprise software solutions, announces the …
CoRegen, Inc. Closes More Than $93 Million Financing
GlobeNewswire
·
July 9, 2025
HOUSTON, July 09, 2025 (GLOBE NEWSWIRE) -- CoRegen, Inc., a biopharmaceutical company pursuing novel treatments for patients impacted by some of the most aggressive forms of cancer, today announced the close of a $93,390,000 million financing. The proceeds …
Magnite to Announce Second Quarter 2025 Financial Results on August 6, 2025
GlobeNewswire
·
July 9, 2025
NEW YORK, July 09, 2025 (GLOBE NEWSWIRE) -- Magnite (Nasdaq: MGNI), the largest independent sell-side advertising company, will announce its financial results for the second quarter ended June 30, 2025 after the market close on Wednesday, August 6, 2025. …
Benitec Biopharma Provides Operational Updates
GlobeNewswire
·
July 9, 2025
-In April 2025 the Sixth and Final Subject of Cohort 1 was Safely Treated with the Low Dose of BB-301 in the Phase 1b/2a Clinical Treatment Study (NCT06185673)- -Independent Data Safety Monitoring Board Review Has Been Completed for All Six Subjects …
‘Lavender & The Butterfly Nation’ Breaks Ground as World’s First GenAI-Hybrid Animated Feature Blending AI with Human Emotion
GlobeNewswire
·
July 9, 2025
HOLLYWOOD, July 09, 2025 (GLOBE NEWSWIRE) -- IMAGENai Inc., a visionary GenAI creative studio, introduces “Lavender …
DIMERx Appoints Biotech Leader Sergio Traversa, PharmD, to Board of Directors
GlobeNewswire
·
July 9, 2025
SAN FRANCISCO, July 09, 2025 (GLOBE NEWSWIRE) -- DIMERx, Inc., a late-stage clinical biopharmaceutical company developing covalently bonded dimer therapeutics, today announced the appointment of Sergio Traversa, PharmD, as an Independent Director to its …
OrangeKloud signs Contract for the Supply and Implementation of Cloud Workspace Terminals
GlobeNewswire
·
July 9, 2025
SINGAPORE, July 09, 2025 (GLOBE NEWSWIRE) -- OrangeKloud Technology Inc. (Nasdaq: ORKT) (“OrangeKloud” or “the Company”), a Singapore-based technology company offering the eMOBIQ® No-Code platform for development of mobile applications, is pleased to …
Immuneering Granted U.S. Composition of Matter Patent for Highly Differentiated Cancer Drug Candidate Atebimetinib
GlobeNewswire
·
July 9, 2025
- Newly issued U.S. composition of matter patent expected to provide exclusivity into 2042, with subsequent opportunity for patent term extension - - First U.S. patent granted on a deep cyclic inhibitor: a once-daily pill that aims to drive longer-lasting …
Layer Raises $6.6M Led by Emergence Capital to Bring Embedded Accounting to the SMB Software Stack
GlobeNewswire
·
July 9, 2025
SAN FRANCISCO, July 09, 2025 (GLOBE NEWSWIRE) -- Layer, the leading embedded accounting platform for small and medium-size business (SMB) software, today announced it has raised $6.6 million in seed funding led by Emergence Capital, with participation from …
Finding certainty in market turmoil: Why more and more investors choose SAVVY MINING
GlobeNewswire
·
July 9, 2025
London, UK, July 09, 2025 (GLOBE NEWSWIRE) -- With Solana (SOL) continuing to expand in the blockchain field, Ripple (XRP) being widely used in cross-border payments in Asia, and Dogecoin (DOGE) regaining the attention of retail investors, the enthusiasm …
Rhythm Pharmaceuticals Announces Oral MC4R Agonist Bivamelagon Achieved Statistically Significant, Clinically Meaningful BMI Reductions in Placebo-controlled Phase 2 Trial in Acquired Hypothalamic Obesity
GlobeNewswire
·
July 9, 2025
-- Bivamelagon achieved BMI reductions in patients with acquired hypothalamic obesity of -9.3% and -7.7% in 600mg and 400mg cohorts, respectively, at 14 weeks -- -- Post-hoc analysis showed BMI reductions in bivamelagon trial were consistent with BMI …
TopFX Expands Asset Offerings with Synthetic Indices Access
GlobeNewswire
·
July 9, 2025
Mahé, Seychelles, July 09, 2025 (GLOBE NEWSWIRE) -- TopFX has now made synthetic indices trading available to all clients through its cTrader platform, marking a turning point for those who prefer structure, speed, and simplicity in the markets. This new …
Sunny Mining launches DOGE/BTC short-term contracts, with weekly new user registrations increasing by 500%
GlobeNewswire
·
July 9, 2025
Los Angeles, California, July 09, 2025 (GLOBE NEWSWIRE) -- GlobeNewswire Sunny Mining, a global frontrunner in crypto cloud mining, with a new series of short-term DOGE and BTC cloud mining contracts, has launched these contracts which are secured with …
Artelo Biosciences Announces Positive Preclinical Efficacy Data for ART26.12 in Osteoarthritis Pain at the 35th Annual International Cannabinoid Research Society Symposium
GlobeNewswire
·
July 9, 2025
SOLANA BEACH, Calif., July 09, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, …